UK Markets close in 25 mins

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3200+0.0700 (+5.60%)
As of 11:05AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 35.6000
52-week low 31.1400
50-day moving average 31.6475
200-day moving average 33.0332

Share statistics

Avg vol (3-month) 31.35M
Avg vol (10-day) 3976.86k
Shares outstanding 5165.88M
Implied shares outstanding 6N/A
Float 8137.46M
% held by insiders 19.27%
% held by institutions 134.79%
Shares short (30 Jan 2023) 44.5M
Short ratio (30 Jan 2023) 42.24
Short % of float (30 Jan 2023) 43.42%
Short % of shares outstanding (30 Jan 2023) 42.71%
Shares short (prior month 29 Dec 2022) 45.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-34,233.88%

Management effectiveness

Return on assets (ttm)-22.00%
Return on equity (ttm)-53.78%

Income statement

Revenue (ttm)425k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-91.00%
Gross profit (ttm)20.38M
EBITDA -145.35M
Net income avi to common (ttm)-196.25M
Diluted EPS (ttm)-3.9390
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)304.06M
Total cash per share (mrq)1.83
Total debt (mrq)17.1M
Total debt/equity (mrq)5.78
Current ratio (mrq)12.25
Book value per share (mrq)2.84

Cash flow statement

Operating cash flow (ttm)-94.47M
Levered free cash flow (ttm)-40.55M